These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35103791)

  • 1. Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer.
    Chin RI; Otegbeye EE; Kang KH; Chang SH; McHenry S; Roy A; Chapman WC; Henke LE; Badiyan SN; Pedersen K; Tan BR; Glasgow SC; Mutch MG; Samson PP; Kim H
    JAMA Netw Open; 2022 Feb; 5(2):e2146312. PubMed ID: 35103791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of long-course oxaliplatin and bolus of fluorouracil based preoperative chemoradiotherapy vs. 5x5Gy radiation plus FOLFOX4 for locally advanced resectable rectal cancer.
    Wang S; Wen F; Zhang P; Wang X; Li Q
    Radiat Oncol; 2019 Jun; 14(1):113. PubMed ID: 31234886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
    Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
    Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer.
    Wright ME; Beaty JS; Thorson AG; Rojas R; Ternent CA
    Dis Colon Rectum; 2019 May; 62(5):568-578. PubMed ID: 30964794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of short-course radiotherapy with total neoadjuvant therapy in the treatment of middle and low rectal cancer].
    Chen CJ; Yang CK; Jian JL; Guan S; Xie MM
    Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(4):271-277. PubMed ID: 36660788
    [No Abstract]   [Full Text] [Related]  

  • 6. Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy.
    Bercz A; Park BK; Pappou E; Nemirovsky D; Sarkar R; Yamner M; Omer D; Verheij FS; Alvarez J; Atri P; Reyngold M; Yaeger R; Wei IH; Wu A; Raj N; Widmar M; Hajj C; Kim MJ; Rao D; Nash GM; Williams V; Shia J; Segal NH; Diaz L; Ganesh K; Weiser MR; Gollub MJ; Paty PB; Horvat N; Zinovoy M; Roth O'Brien D; Sanchez-Vega F; Saltz LB; Crane CH; Cercek A; Gonen M; Garcia-Aguilar J; Smith JJ; Romesser PB
    Ann Oncol; 2024 Nov; 35(11):1003-1014. PubMed ID: 39266364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Short-Course Radiation Therapy vs Long-Course Chemoradiation for Locally Advanced Rectal Cancer.
    Raldow AC; Chen AB; Russell M; Lee PP; Hong TS; Ryan DP; Cusack JC; Wo JY
    JAMA Netw Open; 2019 Apr; 2(4):e192249. PubMed ID: 30977859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical and short-term oncological safety of total neoadjuvant therapy in high-risk locally advanced rectal cancer.
    Ng YY; Seow-En I; Chok AY; Lee TS; Palanisamy P; Tan EK
    ANZ J Surg; 2024 Feb; 94(1-2):175-180. PubMed ID: 37849414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year oncological outcomes after selective neoadjuvant radiotherapy for resectable rectal cancer.
    Banwell VC; Phillips HA; Duff MJ; Speake D; McLean C; Williams LJ; He Y; Paterson HM
    Acta Oncol; 2019 Sep; 58(9):1267-1272. PubMed ID: 31237192
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
    Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
    Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant short-course radiotherapy or chemoradiation plus consolidative chemotherapy followed by radical operation for locally advanced rectal cancer.
    Lee SF; Yip PL; Wo B; Wong NS; Vellayappan BA; Mamon HJ; Lee FAS
    Front Oncol; 2023; 13():1284569. PubMed ID: 38322287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized Controlled Trial of Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy Versus Long-Course Chemoradiotherapy in Locally Advanced Rectal Cancer: Comparison of Overall Response Rates.
    Amariyil A; Pathy S; Sharma A; Kumar S; Pramanik R; Bhoriwal S; Pandey RM
    J Gastrointest Cancer; 2024 Mar; 55(1):373-382. PubMed ID: 37702850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial).
    Kang MK; Park SY; Park JS; Kim HJ; Kim JG; Kang BW; Baek JH; Cho SH; Seo AN; Kim DW; Kim J; Baek SJ; Kim JH; Kim JY; Ha GW; Park EJ; Park IJ; Kim CH; Kang H; Choi GS
    BMC Cancer; 2023 Nov; 23(1):1059. PubMed ID: 37923987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial.
    Zhang MX; Li XB; Guan BJ; Guan GX; Lin XY; Wu XD; Chi P; Xu BH
    BMJ Open; 2019 Mar; 9(3):e025944. PubMed ID: 30904869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer.
    Cho MS; Bae HW; Chang JS; Yang SY; Kim TH; Koom WS; Shin SJ; Choi GS; Kim NK
    Yonsei Med J; 2023 Jun; 64(6):395-403. PubMed ID: 37226566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis of total neoadjuvant therapy with 5 × 5 Gy radiation therapy versus conventional chemoradiotherapy for locally advanced rectal cancer among Peruvians.
    Díaz JFR; Changra HO
    Ecancermedicalscience; 2022; 16():1406. PubMed ID: 36072238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.